Intuitive Surgical Inc（ISRG）股票分析ISRGIntuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Intuitive Surgical Inc is a good buy right now due to its recent earnings beat with an EPS of $2.53, exceeding estimates by 18.78%, and a forward P/E ratio of 33.33, indicating growth potential at a reasonable valuation. The stock has shown a positive momentum with a 5-day change of +6.00% and a current RSI of 76.78, suggesting strong buying interest. However, the main risk is the recent 10% drop in share price following disappointing earnings, which could indicate market volatility ahead.

17 analysts cover ISRG: 11 rate it Buy, 5 Hold and 1 Sell. The average price target is 637.32.